Aspetti Farmacoeconomici dei farmaci Inibitori del Checkpoint Immunitario (ICI)

Personalized medicine represents a notable advance in medical practice, as it allows treatments to be adapted to the genetic and phenotypic characteristics of patients. This approach is particularly consolidated in oncology, where it has revolutionized clinical practice. Personalizing treatment base...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Phármakon
Corporate Authors: Mucherino, Sara, Colonna, Roberto, Lorenzoni, Valentina, Marasco, Ginevra
Formato: Livro
Idioma:Italiano
Publicado: FedOA - Federico II University Press 2024-07-31
Assuntos:
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Pharmacoeconomics, Inhibiting Drugs of the Immune Checkpoint, Pharmacoutilization
Acceso en liña:https://directory.doabooks.org/handle/20.500.12854/142754
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares